CG Oncology Inc. CGON 深 沪
等待开盘 11-04 09:30:00 美东时间
41.41
-1.860
-4.30%
华盛通- 最 高42.94
- 今 开42.61
- 成交量 52.15万股
- 最 低 40.32
- 昨 收 43.27
- 总市值 31.56亿
- 52周最高 45.5594
- 市盈率 静 --
- 换手率 0.68%
- 52周最低 14.80
- 委 比 -43.47%
- 总股本 7622.53万
- 历史最高 50.23
- 量 比 0.64
- 振 幅 6.06%
- 历史最低 14.80
- 每 手 1
- 风险率 5.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ClearBridge SMID Cap Growth Strategy
The ClearBridge SMID Cap Growth Strategy underperformed its Russell 2500 Growth Index benchmark during the third quarter, with the index gaining 10.7%. As such, the performance of SMID growth equitie...
10-13 23:15
古根海姆证券给予CG Oncology“买入”评级
癌症治疗公司CG Oncology（CGON）股价大涨9.1%，此前古根海姆证券以“买入”评级开始覆盖该股，其目标价预示巨大上涨空间。该投行表示看好CG公司...
10-09 03:25
CG Oncology shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and announced a $90 price target.
CG Oncology shares are trading higher after Guggenheim initiated coverage on th...
10-08 23:18
美股大行评级 | 潜在涨幅485.44%！Allarity Therapeutics获机构升目标价至9.25美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从9美元升至9.25美元；JMP证券：维持Crinetics Pharmaceuticals"跑赢大市"评级，目标价从86美元升至143美元
09-29 09:15
JP Morgan Maintains Overweight on CG Oncology, Raises Price Target to $47
JP Morgan analyst Brian Cheng maintains CG Oncology (NASDAQ: CGON) with a Overweight and raises the price target from $41 to $47.
09-26 19:46
Goldman Sachs Remains a Buy on CG Oncology, Inc. (CGON)
Goldman Sachs analyst Corinne Johnson maintained a Buy rating on CG Oncology, I...
09-22 19:05
美股大行评级 | Tigress Financial：维持苹果"强烈买入"评级，目标价升至305美元；杰富瑞维持百度"买入"评级，目标价升至157美元
今日重点评级关注：HC Wainwright & Co.：维持Astria Therapeutics"买入"评级，目标价从16美元升至20美元；HC Wainwright & Co.：维持Avalo Therapeutics"买入"评级，目标价从15美元升至25美元
09-18 10:13
Morgan Stanley Maintains Overweight on CG Oncology, Raises Price Target to $79
Morgan Stanley analyst Jeffrey Hung maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $56 to $79.
09-18 02:00
美股大行评级 | Bernstein：首予Bullish"与大市齐平"评级，目标价60美元
今日重点评级关注：TD Cowen：上调加拿大鹅评级至"买入"，目标价从16美元升至18美元；Vertical Research：上调波音评级至"买入"，目标价从242美元升至270美元
09-09 09:58
CG Oncology Stock Signals Bullish Momentum Ahead
CG Oncology has entered its Phase 2 of the Adhishthana Cycle, signaling a bullish setup. With momentum already building, here's what to track...
09-08 21:08
